EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Association Between Symptom Severity and Medication Adherence in Adults with Bipolar Disorder Reporting Adherence Challenges

Martha Sajatovic, Farren Briggs, Clara Adeniyi, Jacob Koopman, Jessica Black, Celeste Weise, Nicole Fiorelli, Joy Yala, Mohammad Lesanpezeshki, Douglas Einstadter, Jennifer B Levin

Psychopharmacology Bulletin · 2025

DOI: 10.64719/pb.4494 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Psychopharmacology Bulletin, 2025. Verfasst von Martha Sajatovic und 10 weiteren Autor:innen. Beteiligte Einrichtung: Sajatovic, MD, Department of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, OH, USA; Neurological and Behavioral Outcomes…. Hauptthemen laut MEDLINE: Bipolar Disorder, Medication Adherence. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Given the importance of medication adherence among individuals with bipolar disorder (BD), this analysis from an ongoing randomized controlled trial (RCT) examined the relationship between BD symptoms, functioning and adherence in 69 poorly adherent adults with BD.

Method

Study inclusion criteria included being ≥ 18 years old with BD Type 1 or 2, difficulties with medication adherence and actively symptomatic as measured by Brief Psychiatric Rating Scale (BPRS) score ≥ 36, Young Mania Rating Scale (YMRS) > 8 or Montgomery Asberg Depression Rating Scale (MADRS) > 8. Adherence was measured in 2 ways: 1) the self-reported Tablets Routine Questionnaire (TRQ) and 2) electronic pill container monitoring (eCap pillbox). BD symptoms and functioning were measured with the MADRS, YMRS, Clinical Global Impressions Scale (CGI), and Global Assessment of Functioning (GAF). Only screening and baseline data were examined.

Results

Mean age was 42.32 (SD = 12.99) years, with 72.46% (n = 50) female and 43.48% (n = 30) non-white. Mean past 7-day percentage of days with missed BD medications using TRQ was 40.63% (SD = 32.61) and 30.30% (SD = 30.41) at screening and baseline, respectively. Baseline adherence using eCap was 42.16% (SD = 35.85) in those with available eCap data (n = 41). Worse adherence based on TRQ was significantly associated with higher MADRS (p = 0.04) and CGI (p = .03) but lower GAF (p = 0.02). eCAP measured adherence was not significantly associated with clinical variables.

Conclusion

While depression and functioning were approximate markers of adherence, reliance on patient self-report or BD symptom presentation may give an incomplete picture of medication-taking behaviors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bipolar DisorderMedication AdherenceHumansFemaleAdultMaleMiddle AgedSeverity of Illness IndexPsychiatric Status Rating ScalesSelf Report

Stichwörter der Autor:innen

bipolar disorderdepressionmaniamanic depressive disordermedication adherence

Autor:innen und Institutionen

  • Sajatovic, MD, Department of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, OH, USA; Neurological and Behavioral Outcomes Center, University Hospitals Cleveland Medical Center, Cleveland, OH,…
  • Briggs, PhD, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Adeniyi, Department of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
  • Koopman, Department of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
  • Black, Department of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
  • Weise, Department of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, OH, USA.

Förderung

  • NIMH NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Sajatovic, M., Briggs, F., Adeniyi, C., Koopman, J., Black, J., Weise, C., Fiorelli, N., Yala, J., Lesanpezeshki, M., Einstadter, D., & Levin, J. B. (2025). Association Between Symptom Severity and Medication Adherence in Adults with Bipolar Disorder Reporting Adherence Challenges. Psychopharmacology Bulletin. https://doi.org/10.64719/pb.4494

Vancouver

Sajatovic M, Briggs F, Adeniyi C, Koopman J, Black J, Weise C, et al. Association Between Symptom Severity and Medication Adherence in Adults with Bipolar Disorder Reporting Adherence Challenges. Psychopharmacology Bulletin. 2025. doi:10.64719/pb.4494

BibTeX
@article{Sajatovic2025,
  author = {Sajatovic, Martha and Briggs, Farren and Adeniyi, Clara and Koopman, Jacob and Black, Jessica and Weise, Celeste and Fiorelli, Nicole and Yala, Joy and Lesanpezeshki, Mohammad and Einstadter, Douglas and Levin, Jennifer B},
  title = {Association Between Symptom Severity and Medication Adherence in Adults with Bipolar Disorder Reporting Adherence Challenges},
  journal = {Psychopharmacology Bulletin},
  year = {2025},
  doi = {10.64719/pb.4494}
}
Kostenlos starten →